Development of a novel mobile health tool for age-specific dehydration assessment and management in patients with diarrheal disease
开发一种新型移动健康工具,用于腹泻病患者的特定年龄脱水评估和管理
基本信息
- 批准号:10202572
- 负责人:
- 金额:$ 54.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:5 year oldAcute DiarrheaAdolescentAdultAdverse eventAgeAlgorithmsBangladeshBedsBody Weight ChangesCar PhoneCaringCause of DeathCessation of lifeChildChildhoodClinicalClinical TrialsCost SavingsDataDehydrationDevelopmentDiagnosisDiagnosticDiarrheaDiscipline of NursingElderlyEnrollmentEnsureEtiologyFutureHealthHealth PersonnelHealth care facilityHealthcareHospitalizationIV FluidIndividualInpatientsInternational UnitIschemiaLeadLiquid substanceMachine LearningMeasuresModelingMorbidity - disease rateNursesOralOrganOutpatientsPatientsPerformancePhysiciansPhysiologicalPhysiologyPopulationProspective cohortProviderRehydration SolutionsRehydrationsResearchResourcesResuscitationSeveritiesSigns and SymptomsSymptomsTechniquesWorkWorld Health Organizationaccurate diagnosisage groupbaseclinical diagnosticsclinical examinationclinical predictorscost effectivenessdesigndiagnostic accuracydiarrheal diseaseexperiencehemodynamicsimprovedinnovationinternational centerlow and middle-income countriesmHealthmortalitynovelpatient populationpreventsuccesstoolusability
项目摘要
Project Summary
Diarrheal diseases lead to an estimated 2.4 billion episodes of illness and 1.3 million deaths each year, with
the majority of those deaths occurring in adults, adolescents, and children over five years. As the severity of
diarrheal diseases can vary widely, accurately assessing dehydration status remains the most crucial
step in preventing morbidity and mortality. While patients with severe dehydration require hospital
admission and immediate resuscitation with intravenous fluids to prevent hemodynamic compromise, organ
ischemia, and death, those with mild to moderate dehydration can be treated in outpatient settings with
relatively inexpensive oral rehydration solution. Yet, while several tools have been validated for use in children
under five years of age, no clinical diagnostic tool has ever been validated for the assessment of
dehydration severity in adults, adolescents or children over five years of age with acute diarrhea.
Differences in both adult physiology and diarrhea etiology may compromise the accuracy of clinical diagnostic
models developed for use in young children. The proposed research will derive the very first age-specific
clinical diagnostic models created for the assessment of dehydration status in patients over five years of age
with acute diarrhea, incorporate those models into a new mobile health (mHealth) tool, and validate the
performance of this tool in a new population of patients with acute diarrhea.
To accomplish this task, we will enroll a prospective cohort of adults and children over five years of age with
acute diarrhea presenting to the rehydration unit of the International Centre for Diarrhoeal Disease Research,
Bangladesh (icddr,b) in Dhaka, Bangladesh and collect data on presenting clinical signs and symptoms shown
to correlate with dehydration severity in prior studies. We will then employ machine learning techniques to
derive age-specific clinical diagnostic models for assessing dehydration in patients over five years of age with
acute diarrhea. We will conduct formative research among clinicians working at icddr,b to develop an
innovative mobile phone based platform which will incorporate these new age-specific diagnostic models for
rapid use by frontline health workers. Finally, we will validate both the accuracy and reliability of the newly
developed mHealth tool in a new population of adults and children over five years of age with acute diarrhea.
Once developed and properly validated, this novel mHealth tool has the potential to help physicians,
nurses, and other healthcare providers more accurately diagnose dehydration severity and better
determine the optimal management strategy for patients with acute diarrhea. Improved diagnostic
approaches may in turn be shown to reduce both the morbidity and mortality that occurs as a result of missed
diagnoses of dehydration, as well as the adverse events and inappropriate utilization of limited healthcare
resources that can result from inaccurate diagnoses of dehydration.
项目概要
据估计,腹泻病每年导致 24 亿次发病和 130 万人死亡,其中
其中大部分死亡发生在五年以上的成人、青少年和儿童中。由于严重程度
腹泻疾病差异很大,准确评估脱水状态仍然是最重要的
预防发病率和死亡率的步骤。虽然严重脱水的患者需要住院治疗
入院并立即用静脉输液进行复苏,以防止血流动力学损害、器官
缺血和死亡,轻度至中度脱水的患者可以在门诊接受以下治疗:
相对便宜的口服补液。然而,尽管有几种工具已被验证可用于儿童
对于五岁以下的儿童,目前还没有经过验证的临床诊断工具可用于评估
患有急性腹泻的成人、青少年或五岁以上儿童的脱水严重程度。
成人生理学和腹泻病因学的差异可能会影响临床诊断的准确性
为幼儿使用而开发的模型。拟议的研究将得出第一个特定年龄
为评估五岁以上患者脱水状态而创建的临床诊断模型
患有急性腹泻,将这些模型纳入新的移动健康(mHealth)工具中,并验证
该工具在新的急性腹泻患者群体中的表现。
为了完成这项任务,我们将招募一组由成人和五岁以上儿童组成的前瞻性队列
急性腹泻就诊于国际腹泻病研究中心的补液部门,
孟加拉国 (icddr,b) 在孟加拉国达卡收集有关所显示的临床体征和症状的数据
与先前研究中脱水严重程度相关。然后我们将利用机器学习技术来
推导年龄特异性临床诊断模型,用于评估五岁以上患者的脱水情况
急性腹泻。我们将对在 icddr,b 工作的临床医生进行形成性研究,以开发
基于创新手机的平台将整合这些新的针对特定年龄的诊断模型
一线卫生工作者快速使用。最后,我们将验证新方法的准确性和可靠性。
针对患有急性腹泻的成人和五岁以上儿童的新人群开发了移动医疗工具。
一旦开发并经过适当验证,这种新颖的移动医疗工具有潜力帮助医生,
护士和其他医疗保健提供者可以更准确地诊断脱水严重程度并更好地
确定急性腹泻患者的最佳治疗策略。改进的诊断
反过来,这些方法可能会被证明可以降低因错过治疗而导致的发病率和死亡率。
脱水诊断,以及不良事件和有限医疗保健的不当使用
脱水诊断不准确可能导致的资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam Carl Levine其他文献
Adam Carl Levine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam Carl Levine', 18)}}的其他基金
Development of a Mobile Health Personalized Physiologic Analytics Tool for Pediatric Patients with Sepsis
为脓毒症儿科患者开发移动健康个性化生理分析工具
- 批准号:
10268409 - 财政年份:2021
- 资助金额:
$ 54.68万 - 项目类别:
Development of a Mobile Health Personalized Physiologic Analytics Tool for Pediatric Patients with Sepsis
为脓毒症儿科患者开发移动健康个性化生理分析工具
- 批准号:
10671864 - 财政年份:2021
- 资助金额:
$ 54.68万 - 项目类别:
Development of a Mobile Health Personalized Physiologic Analytics Tool for Pediatric Patients with Sepsis
为脓毒症儿科患者开发移动健康个性化生理分析工具
- 批准号:
10472047 - 财政年份:2021
- 资助金额:
$ 54.68万 - 项目类别:
Development of a novel mobile health tool for age-specific dehydration assessment and management in patients with diarrheal disease
开发一种新型移动健康工具,用于腹泻病患者的特定年龄脱水评估和管理
- 批准号:
10431875 - 财政年份:2018
- 资助金额:
$ 54.68万 - 项目类别:
Evaluation of Management Strategies for Maximizing Supportive Care for Patients with Ebola Virus Disease
评估埃博拉病毒病患者最大限度支持护理的管理策略
- 批准号:
9369313 - 财政年份:2017
- 资助金额:
$ 54.68万 - 项目类别:
Assessment of Dehydration in Children with Diarrhea in Resource-Limited Settings
资源有限环境下腹泻儿童脱水的评估
- 批准号:
8548427 - 财政年份:2012
- 资助金额:
$ 54.68万 - 项目类别:
Assessment of Dehydration in Children with Diarrhea in Resource-Limited Settings
资源有限环境下腹泻儿童脱水的评估
- 批准号:
8692494 - 财政年份:2012
- 资助金额:
$ 54.68万 - 项目类别:
Assessment of Dehydration in Children with Diarrhea in Resource-Limited Settings
资源有限环境下腹泻儿童脱水的评估
- 批准号:
8435887 - 财政年份:2012
- 资助金额:
$ 54.68万 - 项目类别:
Assessment of Dehydration in Children with Diarrhea in Resource-Limited Settings
资源有限环境下腹泻儿童脱水的评估
- 批准号:
9281928 - 财政年份:2012
- 资助金额:
$ 54.68万 - 项目类别:
相似国自然基金
猪急性腹泻综合征冠状病毒(SADS-CoV)辅助蛋白NS7a/7b的离子通道活性及其调控细胞凋亡机制的研究
- 批准号:32302841
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型猪冠状病毒SADS-CoV入侵过程中S蛋白与受体识别机制的结构与功能研究
- 批准号:31900879
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
肠道致病菌核型分型及同源克隆鉴定研究
- 批准号:39470647
- 批准年份:1994
- 资助金额:6.0 万元
- 项目类别:面上项目
相似海外基金
Rice bran in ready-to-use therapeutic foods for microbiota-targeted treatment of childhood malnutrition
即用型治疗食品中的米糠用于针对儿童营养不良的微生物群治疗
- 批准号:
10750478 - 财政年份:2023
- 资助金额:
$ 54.68万 - 项目类别:
The Wake Forest Nonhuman Primate Radiation Survivor Cohort
维克森林非人类灵长类辐射幸存者队列
- 批准号:
10462021 - 财政年份:2020
- 资助金额:
$ 54.68万 - 项目类别:
Opiod Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain
阿片类镇痛减量研究 (OARS):管理术后急性手术疼痛
- 批准号:
10193996 - 财政年份:2020
- 资助金额:
$ 54.68万 - 项目类别:
Opiod Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain
阿片类镇痛减量研究 (OARS):管理术后急性手术疼痛
- 批准号:
10670330 - 财政年份:2020
- 资助金额:
$ 54.68万 - 项目类别:
Opiod Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain
阿片类镇痛减量研究 (OARS):管理术后急性手术疼痛
- 批准号:
10452705 - 财政年份:2020
- 资助金额:
$ 54.68万 - 项目类别: